| Asad Bashey, M.D., Ph. D. |
|
Asad Bashey, M.D., Ph. D. is board certified in the subspecialties of medical oncology and hematology and is the clinical research Medical Director for The Blood and Marrow Transplant Program at Northside Hospital.
Training
- University of Dundee in Scotland, where he graduated with Commendation
- Completed residency training at the University of Edinburgh, Scotland
- Fellowship training in bone marrow transplantation and leukemia therapy at the Hammersmith Hospital (Royal Postgraduate Medical School, now Imperial College School of Medicine) in London, UK.
- Awarded Ph.D. from the University of London for his research related to leukemia
- Completed further specialty training at University of California, San Diego (UCSD) Moores Cancer Center in La Jolla, California
Academic Faculty Appointments
- UCSD Moores Cancer Center -Associate Professor: Clinical Director of the Bone Marrow Transplant Program and the Clinical Services Chief for the BMT Division through December 2005.
Society Memberships
- American Society of Clinical Oncology
- American Society of Hematology
- American Society of Blood and Marrow Transplantation
Publications
- Authored and co-authored more than forty-five research articles in peer-reviewed journals and is the primary author of several books including "Non-Myeloblative Allogeneic Transplantation" (2002) and "100 Questions and Answers on Myeloma" (2nd edition 2009)
Dr. Bashey's clinical and research interests include novel approaches to allogeneic bone marrow transplantation, strategies for augmentation of the graft-versus-tumor effect after allogeneic transplantation, and stem cell mobilization, treatment of acute and chronic leukemias and novel; approaches to the management of multiple myeloma and lymphomas. He has received major funding from the National Institutes of Health for his clinical research and has been appointed to the BMT Core Committee of Cancer and Leukemia Group B. He is the Principal Investigator for the Core Clinical Center Award from the National Institutes of Health to the Blood and Marrow Transplant Program at Northside Hospital.
